Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis [0.03%]
一线化疗治疗结外自然杀伤细胞/T细胞淋巴瘤疗效的系统评价和网络 meta 分析
Fei Luo,Jing Nan Wang,Xin Liu et al.
Fei Luo et al.
Background: Treatment with non-anthracycline (ANT)-based chemotherapy has increased survival in patients with extranodal natural killer/T-cell lymphoma (ENKTCL). However, the relative efficacy of various drug combinations...
Validation of the New MINI-CUBE for Clinic Determination of Erythrocyte Sedimentation Rate [0.03%]
新型MINI-CUBE装置检测红细胞沉降率的验证研究
Flaminia Tomassetti,Martina Pelagalli,Eleonora Nicolai et al.
Flaminia Tomassetti et al.
Background: Erythrocyte sedimentation rate (ESR) indirectly measures blood fibrinogen, and it is altered by all those pathological conditions that modify the aggregation of red blood cells. The international guidelines by...
When Lymphoma Strikes the Pancreas: A Rare Presentation of Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in a Human Immunodeficiency Virus-Positive Patient [0.03%]
人免疫缺陷病毒感染者罕见的系统性无间变淋巴瘤激酶阴性的间变大细胞淋巴瘤胰腺受累病例报告
Hehua Hannah Huang,Xin Qing
Hehua Hannah Huang
Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is an uncommon subtype of non-Hodgkin lymphoma, with pancreatic involvement being exceedingly rare and documented in only a handful of case reports. We present ...
Case Reports
Journal of hematology. 2023 Oct;12(5):236-242. DOI:10.14740/jh1138 2023
Could the Crosstalk Between Myeloid-Derived-Suppressor Cells and Regulatory T Cells Have a Role in Beta-Thalassemia? [0.03%]
髓源抑制细胞和调节性T细胞的串扰在β-地中海贫血发病机制中可能发挥作用吗？
Asmaa M Zahran,Omnia El-Badawy,Eman R Badawy et al.
Asmaa M Zahran et al.
Background: Secondary iron overload, alloimmunization, and increased risk of infection are common complications in patients with transfusion-dependent thalassemia (TDT). Regulatory T cells (Tregs) and myeloid-derived supp...
Hemolytic Anemia Requiring Splenectomy in Leigh-Like Syndrome due to the Variant m.10191T>C in MT- ND3 [0.03%]
线粒体DNA MT-ND3基因变异m.10191T>C导致的莱氏综合征样综合征并发需行脾切除的溶血性贫血病例报告
Shaundra M Newstead,Josef Finsterer
Shaundra M Newstead
Reduced-Intensity Anthracycline-Free Chemoimmunotherapy in Elderly Patients With Newly Diagnosed or Relapsed Diffuse Large B-Cell Lymphoma [0.03%]
老年新诊断或复发弥漫大B细胞淋巴瘤患者的低强度无蒽环类化疗免疫治疗
Binoy Yohannan,Adan Rios
Binoy Yohannan
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL); it has a cure rate of approximately 50% with standard anthracycline-based chemoimmunotherapy. However, the clinical outcomes of elderly unfit/frail...
Case Reports
Journal of hematology. 2023 Aug;12(4):176-186. DOI:10.14740/jh1144 2023
Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia [0.03%]
慢性淋巴细胞白血病患者在使用zanubrutinib治疗期间接种5剂新冠疫苗后的局部和全身免疫反应
Maria Andersson,Jinghua Wu,David Wullimann et al.
Maria Andersson et al.
Background: Patients with chronic lymphocytic leukemia (CLL) are vulnerable to coronavirus disease 2019 (COVID-19) and are at risk of inferior response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vacci...
Leukostasis With Isolated Central Nervous System Involvement in Chronic Phase of Chronic Myelogenous Leukemia [0.03%]
慢性粒细胞白血病慢性期孤立中枢神经系统受累致 leukostasis 病例报告
Won Jin Jeon,Suhani Dalal,Jin Hyun Moon et al.
Won Jin Jeon et al.
Chronic myelogenous leukemia (CML) is a hematologic malignancy with unique significance to the field of hematology and oncology, specifically due to the development of tyrosine kinase inhibitors (TKIs). CML often presents with nonspecific s...
Case Reports
Journal of hematology. 2023 Aug;12(4):187-196. DOI:10.14740/jh1150 2023
Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma [0.03%]
利用免疫系统治疗弥漫性大B细胞淋巴瘤的有效方法
Nathan Visweshwar,Juan Felipe Rico,Robert Killeen et al.
Nathan Visweshwar et al.
Diffuse large B-cell lymphoma (DLBCL) is a heterogenous hematological disorder with malignant potential controlled by immunological characteristics of the tumor microenvironment. Rapid breakthrough in the molecular pathways has made immunol...
Hyperammonemic Encephalopathy: A Rare Presentation of Relapsed Multiple Myeloma [0.03%]
高氨血症性脑病：复发多发性骨髓瘤的罕见表现形式
Sasmith R Menakuru,Mona Atta,Nischala Ammannagari et al.
Sasmith R Menakuru et al.
Hyperammonemia is a rare cause of encephalopathy in multiple myeloma in the absence of hepatic involvement. This is the only reported case of a 74-year-old man who presented with multiple myeloma and achieved complete remission but develope...
Case Reports
Journal of hematology. 2023 Jun;12(3):128-132. DOI:10.14740/jh1097 2023